. (1969). Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxidants & Redox Signaling, 8(11-12), 2021-37. https://doi.org/10.1089/ars.2006.8.2021 (Original work published 1969)
M Perluigi
First name:
M
Last name:
Perluigi
. (2018). Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism. Free Radical Biology & Medicine, 114, 84-93. https://doi.org/10.1016/j.freeradbiomed.2017.07.009
. (2018). mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia. Free Radical Biology & Medicine, 114, 94-101. https://doi.org/10.1016/j.freeradbiomed.2017.08.009
. (2018). Down syndrome: From development to adult life to Alzheimer disease. Free Radical Biology & Medicine, 114, 1-2. https://doi.org/10.1016/j.freeradbiomed.2017.10.374
. (2005). In vivo protection of synaptosomes from oxidative stress mediated by Fe2+/H2O2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate. Free Radical Biology & Medicine, 38(8), 1023-31. https://doi.org/10.1016/j.freeradbiomed.2004.12.027 (Original work published 2005)
. (2006). Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42). Journal Of Chromatography. B, Analytical Technologies In The Biomedical And Life Sciences, 833(1), 3-11. https://doi.org/10.1016/j.jchromb.2005.09.024 (Original work published 2006)
. (2006). In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative.. Neurochemistry International, 48(4), 318-27. https://doi.org/10.1016/j.neuint.2005.11.006
. (2006). Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neuroscience Letters, 397(3), 170-3. https://doi.org/10.1016/j.neulet.2005.12.017 (Original work published 2006)
. (2006). Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. European Journal Of Pharmacology, 545(1), 39-50. https://doi.org/10.1016/j.ejphar.2006.06.026 (Original work published 2006)
. (2009). Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathologica, 118(1), 131-50. https://doi.org/10.1007/s00401-009-0517-0
